Se-Hoon Lee

Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i> -Mutated Advanced NSCLC

Byoung Chul Cho, Shun Lu, Enriqueta Felip et al. · New England Journal of Medicine · 2024 · 375 citations · Full text

Medicine, Oncology, Pharmacology +14

Overall Survival with Amivantamab–Lazertinib in <i>EGFR</i> -Mutated Advanced NSCLC

James Chih‐Hsin Yang, Shun Lu, Hidetoshi Hayashi et al. · New England Journal of Medicine · 2025 · 85 citations

Medicine, Oncology, Pharmacology +15

Two Cases of Small Cell Lung Cancer Transformation from EGFR Mutant Adenocarcinoma During AZD9291 Treatment

Jun Soo Ham, Seokhwi Kim, Hee Kyung Kim et al. · Journal of Thoracic Oncology · 2016 · 80 citations · Full text

Medicine, Genetics, Oncology +15

AZD9291 overcomes T790 M-mediated resistance through degradation of EGFRL858R/T790M in non-small cell lung cancer cells

Bo Mi Ku, Yeon-Hee Bae, Jiae Koh et al. · Investigational New Drugs · 2016 · 17 citations

Medicine, Molecular Biology, Oncology +9

Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial

Benjamin Solomon, Ibiayi Dagogo‐Jack, Se-Hoon Lee et al. · JTO Clinical and Research Reports · 2024 · 12 citations · Full text

Medicine, Oncology, Pharmacology +6